RETRACTED: Usefulness of Monitoring Platelet Function by Multiple Electrode Aggregometry in Primary Coronary Artery Bypass Surgery (Retracted article. See vol. 25, pg. 757, 2011)

被引:9
作者
Mengistu, Andinet M. [1 ]
Mayer, Jochen [1 ]
Boldt, Joachim [1 ]
Roehm, Kerstin D. [1 ]
Suttner, Stefan W. [1 ]
机构
[1] Klinikum Ludwigshafen, Dept Anesthesiol & Intens Care Med, D-67063 Ludwigshafen, Germany
关键词
multiple-electrode aggregometry; acetylsalicylic acid; clopidogrel; point of care; cardiac surgery; platelet function; OF-THORACIC-SURGEONS; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; WHOLE-BLOOD; PREOPERATIVE ASPIRIN; PRACTICE GUIDELINE; FUNCTION ANALYZER; GRAFT-SURGERY; TRANSFUSION; CLOPIDOGREL;
D O I
10.1053/j.jvca.2010.02.008
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Antiplatelet therapy is commonly used for the prevention of cardiovascular complications but increases the risk of perioperative bleeding. Multiple-electrode aggregometry (MEA) was investigated for monitoring platelet inhibition by acetylsalicylic acid (ASA) and clopidogrel in patients undergoing elective coronary artery bypass graft (CABG) surgery with regard to clinical outcome as measured by postoperative blood loss and transfusion requirements. Design: A prospective observational study. Setting: A teaching hospital. Participants: One hundred fifty patients scheduled for elective CABG surgery were included: without antiplatelet therapy (group A, n = 50), single ASA exposure (group B, n = 50), and combined therapy with ASA and clopidogrel (group C, n = 50). Measurements and Main Results: MEA was assessed preoperatively using either collagen (COL-MEA) or ADP (ADP-MEA). Postoperative blood loss and transfusion requirements were recorded for 24 hours after surgery. Postoperative blood loss significantly increased only from combined antiplatelet therapy (group A: 572 +/- 297 mL, group B: 721 +/- 356 mL, group C: 865 +/- 346, p < 0.01) and correlated with ADP (r(p) = -0.35, p < 0.01) and COL-MEA (r(p) = -0.23, p > 0.01). COL-MEA and ADP-MEA discriminated between preoperative ASA and clopidogrel intake (ASA: sensitivity = 86.3%, and specificity = 89.3%; clopidogrel: sensitivity = 87.5%, and specificity = 95.1%). The postoperative transfusion risk was increased in patients diagnosed for clopidogrel treatment by ADP-MEA (odds ratio = 2.92; confidence interval: 1.44-5.92; p = 0.005). Conclusions: MEA is a suitable method for the detection of platelet inhibition by ASA and clopidogrel in patients undergoing CABG surgery. In these patients, preoperative ADP MEA seems to indicate patients at risk for postoperative transfusion requirements. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:42 / 47
页数:6
相关论文
共 30 条
[1]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[2]   Transfusion increases the risk of postoperative infection after cardiovascular surgery [J].
Banbury, MK ;
Brizzio, ME ;
Rajeswaran, J ;
Lytle, BW ;
Blackstone, EH .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (01) :131-138
[3]   ADP receptors and clinical bleeding disorders [J].
Cattaneo, M ;
Gachet, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2281-2285
[4]  
Clemetson KJ, 2001, THROMB HAEMOSTASIS, V86, P189
[5]   Comparison of four methods for the determination of platelet function in whole blood in cardiac surgery [J].
Dietrich, GV ;
Schueck, R ;
Menges, T ;
Kiesenbauer, NP ;
Fruehauf, AC ;
Marquardt, I .
THROMBOSIS RESEARCH, 1998, 89 (06) :295-301
[6]   The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin [J].
Dropinski, Jerzy ;
Jakiela, Bogdan ;
Sanak, Marek ;
Wegrzyn, Woiciech ;
Biernat, Marta ;
Dziedzina, Sylvvia ;
Plutecka, Hanna ;
Szczeklik, Andrew .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (01) :201-209
[7]  
Eagle Kim A, 2004, Circulation, V110, pe340
[8]   Effect of blood transfusion on long-term survival after cardiac operation [J].
Engoren, MC ;
Habib, RH ;
Zacharias, A ;
Schwann, TA ;
Riordan, CJ ;
Durham, SJ .
ANNALS OF THORACIC SURGERY, 2002, 74 (04) :1180-1186
[9]   Does the platelet function analyser (PFA-100®) predict blood loss after cardiopulmonary bypass? [J].
Fattorutto, M ;
Pradier, O ;
Schmartz, D ;
Ickx, B ;
Barvais, L .
BRITISH JOURNAL OF ANAESTHESIA, 2003, 90 (05) :692-693
[10]   The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and other antiplatelet agents during operative coronary revascularization (Executive summary) [J].
Ferraris, VA ;
Ferraris, SP ;
Moliterno, DJ ;
Camp, P ;
Walenga, JM ;
Messmore, HL ;
Jeske, WP ;
Edwards, FH ;
Royston, D ;
Shahian, DM ;
Peterson, E ;
Bridges, CR ;
Despotis, G .
ANNALS OF THORACIC SURGERY, 2005, 79 (04) :1454-1461